SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway

Journal of Pathology

Volumn 235, Issue 4, 2015, Pages 559-570

  Sun, Qiao Yang ^a   Ding, Ling Wen ^a   Xiao, Jin Fen ^a   Chien, Wenwen ^a   Lim, Su Lin ^a   Hattori, Norimichi ^a   Goodglick, Lee ^c   Chia, David ^c   Mah, Vei ^c   Alavi, Mohammad ^c   Kim, Sara R ^c   Doan, Ngan B ^c   Said, Jonathan W ^c   Loh, Xin Yi ^a   Xu, Liang ^a   Liu, Li Zhen ^a   Yang, Henry ^a   Hayano, Takahide ^a   Shi, Shuo ^d   Xie, Dong ^d   Lin, De Chen ^a,b   Phillip Koeffler, H ^a,b   more..

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Lung; SETDB1; Tumourigenesis; WNT

Indexed keywords

BETA CATENIN; METHYLTRANSFERASE; PROTEIN P53; SETDB1 ENZYME; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; WNT PROTEIN; PROTEIN METHYLTRANSFERASE; SETDB1 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SETDB1 GENE; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; CANCER GRADING; CANCER TRANSPLANTATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HCT116 CELL LINE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; TIME; WNT SIGNALING PATHWAY;

ANIMALS; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE, NUDE; NEOPLASM GRADING; NEOPLASM TRANSPLANTATION; PROTEIN METHYLTRANSFERASES; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEIN P53; WNT SIGNALING PATHWAY;

EID: 84922707525     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4482     Document Type: Article

References (50)

1. Soda M, Choi YL, Enomoto M, et al. Identifcation of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448: 561-566.
2. Crino L, Weder W, van Meerbeeck J, et al. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(suppl 5): v103-115.
3. Bell DW, Brannigan BW, Matsuo K, et al. Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms. Clin Cancer Res 2008; 14: 4079-4084.
4. Shi Y, Au JS, Thongprasert S, et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology. J Thorac Oncol 2014; 9: 154-162.
5. Mano H, Takeuchi K. EML4-ALK fusion in lung. Am J Pathol 2010; 176: 1553-1554.
6. Soda M, Takada S, Takeuchi K, et al. A mouse model for EML4-ALK-positive lung cancer. Proc Natl Acad Sci USA 2008; 105: 19893-19897.
7. Bhaumik SR, Smith E, Shilatifard A. Covalent modifcations of histones during development and disease pathogenesis. Nat Struct Mol Biol 2007; 14: 1008-1016.
8. Shilatifard A. Chromatin modifcations by methylation and ubiquiti-nation: implications in the regulation of gene expression. Annu Rev Biochem 2006; 75: 243-269.
9. Strahl BD, Allis CD. The language of covalent histone modifcations. Nature 2000; 403: 41-45.
10. Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone code? Curr Opin Genet Dev 2005; 15: 163-176.
11. Shahbazian MD, Grunstein M. Functions of site-specifc histone acetylation and deacetylation. Annu Rev Biochem 2007; 76: 75-100.
12. Miao F, Natarajan R. Mapping global histone methylation patterns in the coding regions of human genes. Mol Cell Biol 2005; 25: 4650-4661.
13. Kouzarides T. Histone methylation in transcriptional control. Curr Opin Genet Dev 2002; 12: 198-209.
14. Schultz DC, Ayyanathan K, Negorev D, et al. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specifc methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-fnger proteins. Genes Dev 2002; 16: 919-932.
15. Loyola A, Tagami H, Bonaldi T, et al. The HP1α-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin. EMBO Rep 2009; 10: 769-775.
16. Matsui T, Leung D, Miyashita H, et al. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 2010; 464: 927-931.
17. Hayano T, Garg M, Yin D, et al. SOX7 is down-regulated in lung cancer. J Exp Clin Canc Res 2013; 32: 17.
18. Shi S, Deng YZ, Zhao JS, et al. RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway. J Biol Chem 2012; 287: 7845-7858.
19. Mah V, Seligson DB, Li A, et al. Aromatase expression predicts survival in women with early-stage non-small cell lung cancer. Cancer Res 2007; 67: 10484-10490.
20. Huerta-Yepez S, Yoon NK, Hernandez-Cueto A, et al. Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival. BMC Cancer 2011; 11: 259.
21. Bilodeau S, Kagey MH, Frampton GM, et al. SETDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev 2009; 23: 2484-2489.
22. Holland JD, Klaus A, Garratt AN, et al. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol 2013; 25: 254-264.
23. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005; 434: 843-850.
24. Caruso A, Motolese M, Iacovelli L, et al. Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells. J Neurocytol 2006; 98: 364-371.
25. Pencheva N, Tran H, Buss C, et al. Convergent Multi-miRNA Targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 2012; 151: 1068-1082.
26. Ueno K, Hirata H, Majid S, et al. IGFBP-4 activates the Wnt/β-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma. Int J Cancer 2011; 129: 2360-2369.
27. Zhang J, Zhang X, Zhang L, et al. LRP8 mediates Wnt/β-catenin signaling and controls osteoblast differentiation. J Bone Miner Res 2012; 27: 2065-2074.
28. Flahaut M, Meier R, Coulon A, et al. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway. Oncogene 2009; 28: 2245-2256.
29. Barolo S. Transgenic Wnt/TCF pathway reporters: all you need is Lef? Oncogene 2006; 25: 7505-7511.
30. Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 2006; 5: 997-1014.
31. Dvory-Sobol H, Sagiv E, Kazanov D, et al. Targeting the active P-catenin pathway to treat cancer cells. Mol Cancer Ther 2006; 5: 2861-2871.
32. Nicholas S. Tolwinski, Wieschaus E. A nuclear function for Armadillo/p-catenin. PLoS Biol 2004; 2: 8.
33. Karimi MM, Goyal P, Maksakova IA, et al. DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem Cell 2011; 8: 676-687.
34. Ceol CJ, Houvras Y, Jane-Valbuena J, et al. The histone methyltrans-ferase SETDB1 is recurrently amplifed in melanoma and accelerates its onset. Nature 2011; 471: 513-517.
35. Rodriguez-Paredes M, de Paz AM, Simó-Riudalbas L, et al. Gene amplifcation of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis. Oncogene 2013; 33: 2807-2813.
36. Fodde R, Brabletz T. Wnt/p-catenin signaling in cancer stemness and malignant behavior. Curr Opin ChemBiol 2007; 19: 150-158.
37. Hirata A, Utikal J, Yamashita S, et al. Dose-dependent roles for canonical Wnt signalling in de novo crypt formation and cell cycle properties of the colonic epithelium. Development 2013; 140: 66-75.
38. de Sousa EM, Vermeulen L, Richel D, et al. Targeting Wnt signaling in colon cancer stem cells. Clin Cancer Res 2011; 17: 647-653.
39. Hoffmeyer K, Raggioli A, Rudloff S, et al. Wnt/p-catenin signaling regulates telomerase in stem cells and cancer cells. Science 2012; 336: 1549-1554.
40. Zhang Y, Toh L, Lau P, et al. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/p-catenin pathway in human cancer. J Biol Chem 2012; 287: 32494-32511.
41. Zhao X, Malhotra GK, Lele SM, et al. Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate. Proc Natl Acad Sci USA 2010; 107: 14146-14151.
42. He B, Barg RN, You L, et al. Wnt signaling in stem cells and non-small-cell lung cancer. Clin Lung Cancer 2005; 7: 54-60.
43. Brinkman AB, Roelofsen T, Pennings SW, et al. Histone modifcation patterns associated with the human X chromosome. EMBO Rep 2006; 7: 628-634.
44. Vakoc CR, Mandat SA, Olenchock BA, et al. Histone H3 lysine 9 methylation and HP1y are associated with transcription elongation through mammalian chromatin. Mol Cell 2005; 19: 381-391.
45. Hahn MA, Wu X, Li AX, et al. Relationship between gene body DNA methylation and intragenic H3K9me3 and H3K36me3 chromatin marks. PLoS One 2011; 6: e18844.
46. Lundberg LE, Stenberg P, Larsson J. HP1a, Su(var)3-9, SETDB1 and POF stimulate or repress gene expression depending on genomic position, gene length and expression pattern in Drosophila melanogaster. Nucleic Acids Res 2013; 41: 4481-4494.
47. Bittencourt D, Wu D-Y, Jeong KW, et al. G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of glucocorticoid receptor target genes. Proc Natl Acad Sci USA 2012; 109: 19673-19678.
48. Purcell DJ, Jeong KW, Bittencourt D, et al. A distinct mechanism for coactivator versus corepressor function by histone methyltrans-ferase G9a in transcriptional regulation. J Biol Chem 2011; 286: 41963-41971.
49. Lee ST, Li Z, Wu Z, et al. Context-specifc regulation of NF-KB target gene expression by EZH2 in breast cancers. Mol Cell 2011; 43: 798-810.
50. Fritsch L, Robin P, Mathieu JR, et al. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol Cell 2010; 37: 46-56.